Guardant Health (GH) Cash from Financing Activities (2017 - 2026)

Guardant Health has reported Cash from Financing Activities for 10 years, with the latest figure at $23.0 million in Q2 2026.

• Quarterly Cash from Financing Activities rose 1317.12% year-over-year to $23.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $737.8 million (up 1138.48% YoY) and the FY2025 annual result came in at $671.1 million, up 67482.83% from the prior year.
• Cash from Financing Activities climbed to $23.0 million in Q2 2026 per GH's latest filing, from -$21.6 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $732.0 million in Q4 2025 and troughed at -$172.1 million in Q2 2022.
• A 5-year average of $53.3 million and a median of $806000.0 in 2022 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities plunged 7016.67% in 2023, then jumped 25041.33% in 2025.
• Over 5 years, Cash from Financing Activities stood at $2.3 million in 2022, then soared by 3807.16% to $90.6 million in 2023, then slumped by 103.24% to -$2.9 million in 2024, then surged by 25041.33% to $732.0 million in 2025, then tumbled by 96.86% to $23.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $23.0 million, -$21.6 million, and $732.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.